GSK Investigational Site

Monserrato, Sardinia 09042

0 studies enrolling now · 2 studies all time

What they study most

Diabetes Mellitus, Type 1, Lung Cancer, Non-Small Cell

Studies at this site

• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1 — Completed